B. Metzler Seel. Sohn & Co. AG / ABT
B. Metzler Seel. Sohn & Co. AG’s Abbott Laboratories Position
Does B. Metzler Seel. Sohn & Co. AG own Abbott Laboratories (ABT)? Yes — 1.82M shares worth $187M (+1.74% of its 13F portfolio) as of Q1 2026, up from 1.81M shares the prior filed quarter.
Position Value
$187M
Q1 2026
Shares
1.82M
% of Portfolio
+1.74%
Quarters Held
18
currently held
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 1.82M | $187M | +1.74% |
| Q4 2025 | 1.81M | $226M | +1.98% |
| Q3 2025 | 1.75M | $235M | +2.07% |
| Q2 2025 | 1.73M | $235M | +2.25% |
| Q1 2025 | 1.72M | $228M | +2.34% |
| Q4 2024 | 914.6K | $103M | +1.06% |
| Q3 2024 | 226.0K | $26M | +0.26% |
| Q2 2024 | 129.6K | $13M | +0.13% |
| Q1 2024 | 134.2K | $15M | +0.17% |
| Q4 2023 | 137.2K | $15M | +0.19% |
| Q3 2023 | 86.2K | $8M | +0.13% |
| Q2 2023 | 86.1K | $9M | +0.13% |
| Q1 2023 | 80.8K | $8M | +0.13% |
| Q4 2022 | 82.6K | $9M | +0.15% |
| Q3 2022 | 77.9K | $8M | +0.14% |
| Q2 2022 | 85.4K | $9M | +0.15% |
| Q1 2022 | 103.8K | $12M | +0.16% |
| Q4 2021 | 100.1K | $14M | +0.18% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See B. Metzler Seel. Sohn & Co. AG’s full portfolio or all institutional holders of ABT.